logo
US deal: Why India must not trade under coercion

US deal: Why India must not trade under coercion

Deccan Herald15-07-2025
India is in the midst of negotiations for a trade deal with the United States under an environment of unpredictability laced with unabashed and overt arm-twisting that has become the signature call of that nation under President Donald Trump. These are understandably difficult negotiations, and a lot is at stake given that the US remains one of India's most significant trade partners, reflected in the trade numbers and in deep ties seen through the lens of the large and vibrant Indian community in the US and the number of Indians who flock to the US for work, tourism, or to study. The US has extended the deadline for a trade deal from July 9 to August 1 under the threat of punitive tariffs of 26% if an agreement is not reached by then..The extension signals hope and optimism that a deal is possible, but it equally signals that the US side is pushing hard to see if India will bend under pressure. Another explanation is that the extension in itself is a case of 'TACO', or 'Trump Always Chickens Out', given that blanket tariffs on the rest of the world, as envisaged by the US, are not sustainable. But this is less likely with the dominant mood in Washington being to push hard, unmindful of the consequences, and India not being in a very strong position to dictate terms. Further, the US has extracted significant concessions from others, including the UK, and would demand that India, too, fall in line..Of course, the people of India would expect the country not to bend to anything unreasonable, even though making such demands has become the currency of the US. In this context, it is good to delink the success or failure of a trade deal with the performance or the influence of the Narendra Modi government. In other words, this government should ignore image management within the nation vis-a-vis the trade deal and take tough calls that protect Indian interests, even if this runs the risk of not having a trade deal. We may have a deal and be worse off as a nation if India allows concessions and gives in where it should not; we may equally not have a trade deal and be worse off in different ways because the tariffs will impact trade and hurt India and its exports..The latter will create disruption in the immediate, but it has chances of some mitigation with the US in a trade war against all that will likely bring some reversals over time, as its own economy will not be able to take the hit of tariffs beyond a point. Besides, this will be a signal to the world that India will not and should not be pushed. Having a trade deal by granting undue concessions can be far worse since it may open Indian markets in ways and to products and services that will have long-lasting impacts on the nation. The risks are many, but they will take their toll long after the deal is signed, so this is the space to be more watchful. Powerful US lobbies sitting close to, if not right within, the White House are at work pushing for what India will see as undue concessions..Concerns in dairy, agriculture sectors.In this context, two hot-button items that appear to have emerged are the US push for exports of GM crops and cow milk to India. None of these are new demands. They cannot be part of discussions if the Indian side makes it clear that no negotiations on these are possible. For example, India requires that dairy products used as food must be from animals that are not given blood meals or given feeds containing internal organs or tissues of ruminant or porcine origin. This is a perfectly fair and reasonable requirement – cows and buffaloes used for milk production are herbivores and must not be given any animal products as food..Further, milk in the Indian context is culturally sensitive, given that it is used for religious offerings and in sweets for auspicious occasions. Yet, the US position as articulated in the US' '2025 National Trade Estimate Report on Foreign Trade Barriers (FTB)' is that Indian requirements 'lack a discernible animal health or human health justification'. Such a sectoral opening up will kill the Indian dairy sector. It will mix up imported US milk that contains recombinant bovine growth hormone (rBGH), which has been approved in the US since 1993 to increase milk production in cows but is banned in the European Union and Canada. Drinking milk from these sources is linked to higher levels of IGF-1 in humans. IGF-1 is a growth hormone which, at high levels, is said to be linked to prostate, breast, colorectal, and other cancers though the linkage is not definitive, according to the American Cancer Society..On GM crops, the Alliance for Sustainable and Holistic Agriculture, or ASHA-Kisan Swaraj network, which brings together farmers and agriculturists, has written to the government appealing against any concessions to the US. In a letter, the alliance said: 'We strongly urge you to stand firm and unequivocally reject any such move, which would have serious and irreparable implications for India's agriculture, biosafety, public health, rural livelihoods, and seed and food sovereignty.'.The US wants much more than this. Take the example of stent prices, which were capped in India when the regulators found that price inflation was extremely high. Everyone made merry while patients suffered, till the caps came in. The US in the 2025 FTB report has argued that 'price controls (on coronary stents and knee implants) have not been increased in line with inflation and do not differentiate based on the cost of production or technological innovation, which dissuades US companies from serving the market.' The drift is clear. The US wants to extract, if not extort. India must resist..(The writer is a journalist and faculty member at SPJIMR; Syndicate: The Billion Press)
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

India-UK FTA to boost bilateral trade for pharma, medtech, say industry bodies
India-UK FTA to boost bilateral trade for pharma, medtech, say industry bodies

Mint

time12 minutes ago

  • Mint

India-UK FTA to boost bilateral trade for pharma, medtech, say industry bodies

The India-UK free trade agreement, signed on Thursday, is expected to open up new opportunities for Indian pharmaceutical and medical device makers. The deal is also expected to improve access to medical devices from the UK in India. Medical device manufacturers anticipate an increase in trade between the two countries but are awaiting clarity on non-tariff measures and on whether regulatory processes will be streamlined. 'Previously, medical devices imported into the UK were duty-free, so tariff restrictions were not an issue but regulatory approval costs and time were a challenge,' said Rajiv Nath, forum coordinator of industry body Association of Indian Medical Device Industry (Aimed). The body had previously sought recognition of regulatory approvals from the CDSCO or the Quality Council of India's voluntary Indian Certification for medical devices to fast-track approvals by the UK's Medicines and Healthcare products Regulatory Agency (MHRA). 'We look forward to an update on this,' said Nath. However, medtech manufacturers are also seeking strict monitoring of imports to India, to prevent other countries rerouting products into India through the UK. Mint had previously reported that domestic manufacturers raised concerns over the possibility of Chinese-origin products being routed through the UK to exploit the zero-tariff provisions under the FTA. India levies about 7.5% import duties on medical devices from the UK, which are expected to come down in a phased manner after the deal, Nath said. In 2024, medical device exports to the UK increased by 13% year-on-year to ₹ 1,015 crore, while imports from the UK rose 36% to ₹ 2,295 crore, according to Exim data. 'It not only strengthens trade ties but also opens new avenues for advanced technology collaborations between Indian and UK companies,' Himanshu Baid, managing director of Poly Medicure Ltd, said in a statement. 'With India exporting medical devices worth approximately $115 million to the UK, one of our top 10 export destinations, this agreement is poised to further boost our presence,' he added. The trade deal is also expected to open up the market for India's generic drugmakers. 'As per the indications, the pharma sector will have opportunities to supply affordable and quality assured medicine contributing to better patient care in the UK,' said Sudarshan Jain, secretary general of the Indian Pharmaceutical Alliance (IPA). 'We are awaiting further details to identify specific areas where these opportunities can be effectively leveraged,' he added. Generic players like Lupin, Biocon, Dr. Reddy's Laboratories and Wockhardt, which have exposure to the UK market, could stand to benefit.

UK, India say no room for double standards on terrorism in Modi–Starmer talks
UK, India say no room for double standards on terrorism in Modi–Starmer talks

New Indian Express

time12 minutes ago

  • New Indian Express

UK, India say no room for double standards on terrorism in Modi–Starmer talks

NEW DELHI: India and the United Kingdom on Thursday sent a strong, united message against terrorism, with both Prime Minister Narendra Modi and his British counterpart Keir Starmer agreeing that there can be no double standards in tackling extremism. Following a bilateral meeting at the Chequers Estate, Modi thanked Starmer for the UK's strong condemnation of the April terrorist attack in Pahalgam, Jammu and Kashmir, which claimed 26 lives. 'We are united in our view that there can be no place for double standards in the fight against terrorism,' Modi said. 'We also agree that forces with extremist ideologies must not be allowed to misuse democratic freedoms. Those who misuse democratic freedoms to undermine democracy itself must be held to account.' The statement, also seen as a veiled reference to pro-Khalistani activities abroad, comes amid growing Indian concern over threats to Indian diplomats and missions in the UK. Foreign Secretary Vikram Misri later said that India had raised the issue during the bilateral talks. Both sides reaffirmed their commitment to enhancing cooperation between their security agencies, including on the extradition of economic offenders, a longstanding demand from India involving several high-profile fugitives residing in the UK. The two leaders also discussed regional and global challenges. 'We exchanged views on peace and stability in the Indo-Pacific, the conflict in Ukraine, and the situation in West Asia,' Modi said. 'India supports the early restoration of peace and stresses that respect for the sovereignty and territorial integrity of all nations is essential. The demand of today's era is not expansionism, but developmentalism.' Modi also expressed condolences for British nationals who died in last month's Air India crash in Ahmedabad. The meeting, which included a private one-on-one between the leaders, also laid the foundation for a long-term bilateral agenda. A 'Vision 2035' roadmap is being drafted to energize the India–UK Comprehensive Strategic Partnership over the next decade, spanning trade, defence, clean energy, and technology cooperation.

PM Modi meets King Charles, presents tree sapling under ‘Ek Ped Maa Ke Naam'
PM Modi meets King Charles, presents tree sapling under ‘Ek Ped Maa Ke Naam'

Hindustan Times

time12 minutes ago

  • Hindustan Times

PM Modi meets King Charles, presents tree sapling under ‘Ek Ped Maa Ke Naam'

Prime Minister Narendra Modi met King Charles III at Sandringham House on Thursday as part of his official visit to the United Kingdom. PM Narendra Modi meets King Charles at Sandringham House during UK visit. (X-@RoyalFamily) During the meeting, Modi presented the King with a sapling of Davidia involucrata 'Sonoma', commonly known as the Sonoma dove tree or handkerchief tree. The gesture was made under the Prime Minister's 'Ek Ped Maa Ke Naam' initiative, which encourages people to plant a tree in tribute to their mothers. 'This afternoon, The King received the Prime Minister of the Republic of India, @NarendraModi, at Sandringham House. During their time together, His Majesty was given a tree to be planted this Autumn, inspired by the environmental initiative launched by the Prime Minister, 'Ek Ped Maa Ke Naam', which encourages people to plant a tree in tribute to their mothers,' the Royal Family said in a post on X. The Sonoma dove tree is an ornamental species known for its large white bracts that resemble handkerchiefs or doves. Unlike the standard Davidia involucrata, which can take up to 20 years to bloom, the 'Sonoma' cultivar flowers within two to three years of planting.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store